These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16103886)

  • 1. The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins.
    Thomas M; Massimi P; Navarro C; Borg JP; Banks L
    Oncogene; 2005 Sep; 24(41):6222-30. PubMed ID: 16103886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.
    Nakagawa S; Huibregtse JM
    Mol Cell Biol; 2000 Nov; 20(21):8244-53. PubMed ID: 11027293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase.
    Pim D; Thomas M; Javier R; Gardiol D; Banks L
    Oncogene; 2000 Feb; 19(6):719-25. PubMed ID: 10698489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation.
    Massimi P; Gammoh N; Thomas M; Banks L
    Oncogene; 2004 Oct; 23(49):8033-9. PubMed ID: 15378012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
    Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
    J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of the discs large tumour suppressor protein controls its membrane localisation and enhances its susceptibility to HPV E6-induced degradation.
    Massimi P; Narayan N; Cuenda A; Banks L
    Oncogene; 2006 Jul; 25(31):4276-85. PubMed ID: 16532034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli.
    Takizawa S; Nagasaka K; Nakagawa S; Yano T; Nakagawa K; Yasugi T; Takeuchi T; Kanda T; Huibregtse JM; Akiyama T; Taketani Y
    Genes Cells; 2006 Apr; 11(4):453-64. PubMed ID: 16611247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.
    Zhang Y; Dasgupta J; Ma RZ; Banks L; Thomas M; Chen XS
    J Virol; 2007 Apr; 81(7):3618-26. PubMed ID: 17267502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins.
    Pim D; Thomas M; Banks L
    Oncogene; 2002 Nov; 21(53):8140-8. PubMed ID: 12444549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The high-risk HPV E6 target scribble (hScrib) is required for HPV E6 expression in cervical tumour-derived cell lines.
    Kranjec C; Tomaić V; Massimi P; Nicolaides L; Doorbar J; Banks L
    Papillomavirus Res; 2016 Dec; 2():70-77. PubMed ID: 29074188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.
    Thomas M; Glaunsinger B; Pim D; Javier R; Banks L
    Oncogene; 2001 Sep; 20(39):5431-9. PubMed ID: 11571640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions.
    Kranjec C; Banks L
    J Virol; 2011 Feb; 85(4):1757-64. PubMed ID: 21123374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background.
    Massimi P; Shai A; Lambert P; Banks L
    Oncogene; 2008 Mar; 27(12):1800-4. PubMed ID: 17934525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDZ domains and viral infection: versatile potentials of HPV-PDZ interactions in relation to malignancy.
    Nagasaka K; Kawana K; Osuga Y; Fujii T
    Biomed Res Int; 2013; 2013():369712. PubMed ID: 24093094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation.
    Gardiol D; Kühne C; Glaunsinger B; Lee SS; Javier R; Banks L
    Oncogene; 1999 Sep; 18(40):5487-96. PubMed ID: 10523825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators.
    Tomaić V; Gardiol D; Massimi P; Ozbun M; Myers M; Banks L
    Oncogene; 2009 Jan; 28(1):1-8. PubMed ID: 18820705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein.
    Pim D; Tomaic V; Banks L
    J Virol; 2009 Oct; 83(19):9863-74. PubMed ID: 19640984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
    Thatte J; Banks L
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The high-risk HPV E6 oncoprotein preferentially targets phosphorylated nuclear forms of hDlg.
    Narayan N; Subbaiah VK; Banks L
    Virology; 2009 Apr; 387(1):1-4. PubMed ID: 19307009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines.
    García-Alai MM; Dantur KI; Smal C; Pietrasanta L; de Prat-Gay G
    Biochemistry; 2007 Jan; 46(2):341-9. PubMed ID: 17209544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.